Timothy M Rawson1,2,3, Luke S P Moore1,4,5, Nina Zhu1, Nishanthy Ranganathan3,4, Keira Skolimowska3,4, Mark Gilchrist3,4, Giovanni Satta3,4, Graham Cooke3,4, Alison Holmes1,2,3,4. 1. National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom. 2. Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom. 3. Department of Infectious Diseases, Imperial College London, South Kensington, United Kingdom. 4. Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom. 5. Chelsea & Westminster NHS Foundation Trust, London, United Kingdom.
Abstract
BACKGROUND: To explore and describe the current literature surrounding bacterial/fungal coinfection in patients with coronavirus infection. METHODS: MEDLINE, EMBASE, and Web of Science were searched using broad-based search criteria relating to coronavirus and bacterial coinfection. Articles presenting clinical data for patients with coronavirus infection (defined as SARS-1, MERS, SARS-CoV-2, and other coronavirus) and bacterial/fungal coinfection reported in English, Mandarin, or Italian were included. Data describing bacterial/fungal coinfections, treatments, and outcomes were extracted. Secondary analysis of studies reporting antimicrobial prescribing in SARS-CoV-2 even in absence of coinfection was performed. RESULTS: 1007 abstracts were identified. Eighteen full texts reporting bacterial/fungal coinfection were included. Most studies did not identify or report bacterial/fungal coinfection (85/140; 61%). Nine of 18 (50%) studies reported on COVID-19, 5/18 (28%) on SARS-1, 1/18 (6%) on MERS, and 3/18 (17%) on other coronaviruses. For COVID-19, 62/806 (8%) patients were reported as experiencing bacterial/fungal coinfection during hospital admission. Secondary analysis demonstrated wide use of broad-spectrum antibacterials, despite a paucity of evidence for bacterial coinfection. On secondary analysis, 1450/2010 (72%) of patients reported received antimicrobial therapy. No antimicrobial stewardship interventions were described. For non-COVID-19 cases, bacterial/fungal coinfection was reported in 89/815 (11%) of patients. Broad-spectrum antibiotic use was reported. CONCLUSIONS: Despite frequent prescription of broad-spectrum empirical antimicrobials in patients with coronavirus-associated respiratory infections, there is a paucity of data to support the association with respiratory bacterial/fungal coinfection. Generation of prospective evidence to support development of antimicrobial policy and appropriate stewardship interventions specific for the COVID-19 pandemic is urgently required.
BACKGROUND: To explore and describe the current literature surrounding bacterial/fungal coinfection in patients with coronavirus infection. METHODS: MEDLINE, EMBASE, and Web of Science were searched using broad-based search criteria relating to coronavirus and bacterial coinfection. Articles presenting clinical data for patients with coronavirus infection (defined as SARS-1, MERS, SARS-CoV-2, and other coronavirus) and bacterial/fungal coinfection reported in English, Mandarin, or Italian were included. Data describing bacterial/fungal coinfections, treatments, and outcomes were extracted. Secondary analysis of studies reporting antimicrobial prescribing in SARS-CoV-2 even in absence of coinfection was performed. RESULTS: 1007 abstracts were identified. Eighteen full texts reporting bacterial/fungal coinfection were included. Most studies did not identify or report bacterial/fungal coinfection (85/140; 61%). Nine of 18 (50%) studies reported on COVID-19, 5/18 (28%) on SARS-1, 1/18 (6%) on MERS, and 3/18 (17%) on other coronaviruses. For COVID-19, 62/806 (8%) patients were reported as experiencing bacterial/fungal coinfection during hospital admission. Secondary analysis demonstrated wide use of broad-spectrum antibacterials, despite a paucity of evidence for bacterial coinfection. On secondary analysis, 1450/2010 (72%) of patients reported received antimicrobial therapy. No antimicrobial stewardship interventions were described. For non-COVID-19 cases, bacterial/fungal coinfection was reported in 89/815 (11%) of patients. Broad-spectrum antibiotic use was reported. CONCLUSIONS: Despite frequent prescription of broad-spectrum empirical antimicrobials in patients with coronavirus-associated respiratory infections, there is a paucity of data to support the association with respiratory bacterial/fungal coinfection. Generation of prospective evidence to support development of antimicrobial policy and appropriate stewardship interventions specific for the COVID-19 pandemic is urgently required.
Authors: Maciej M Kowalik; Piotr Trzonkowski; Magdalena Łasińska-Kowara; Andrzej Mital; Tomasz Smiatacz; Miłosz Jaguszewski Journal: Cardiol J Date: 2020-05-07 Impact factor: 2.737
Authors: Matteo Bassetti; Daniele Roberto Giacobbe; Paolo Bruzzi; Emanuela Barisione; Stefano Centanni; Nadia Castaldo; Silvia Corcione; Francesco Giuseppe De Rosa; Fabiano Di Marco; Andrea Gori; Andrea Gramegna; Guido Granata; Angelo Gratarola; Alberto Enrico Maraolo; Malgorzata Mikulska; Andrea Lombardi; Federico Pea; Nicola Petrosillo; Dejan Radovanovic; Pierachille Santus; Alessio Signori; Emanuela Sozio; Elena Tagliabue; Carlo Tascini; Carlo Vancheri; Antonio Vena; Pierluigi Viale; Francesco Blasi Journal: Infect Dis Ther Date: 2021-07-30
Authors: Tyra M Avery; RaNashia L Boone; Jacky Lu; Sabrina K Spicer; Miriam A Guevara; Rebecca E Moore; Schuyler A Chambers; Shannon D Manning; Leon Dent; Dana Marshall; Steven M Damo; Steven D Townsend; Jennifer A Gaddy Journal: ACS Infect Dis Date: 2021-06-09 Impact factor: 5.084
Authors: Nicholas Hartog; William Faber; Austin Frisch; Jacob Bauss; Caleb P Bupp; Surender Rajasekaran; Jeremy W Prokop Journal: Expert Rev Proteomics Date: 2021-04-05 Impact factor: 3.940
Authors: Jessica J Manson; Colin Crooks; Meena Naja; Amanda Ledlie; Bethan Goulden; Trevor Liddle; Emon Khan; Puja Mehta; Lucia Martin-Gutierrez; Kirsty E Waddington; George A Robinson; Liliana Ribeiro Santos; Eve McLoughlin; Antonia Snell; Christopher Adeney; Ina Schim van der Loeff; Kenneth F Baker; Christopher J A Duncan; Aidan T Hanrath; B Clare Lendrem; Anthony De Soyza; Junjie Peng; Hajar J'Bari; Mandy Greenwood; Ellie Hawkins; Hannah Peckham; Michael Marks; Tommy Rampling; Akish Luintel; Bryan Williams; Michael Brown; Mervyn Singer; Joe West; Elizabeth C Jury; Matthew Collin; Rachel S Tattersall Journal: Lancet Rheumatol Date: 2020-08-21
Authors: Fernanda Meira; Estela Moreno-García; Laura Linares; Irene Macaya; Adria Tomé; Marta Hernández-Meneses; Laia Albiach; Laura Morata; Laura Letona; Marta Bodro; Alberto Cózar-Llistó; Celia Cardozo; Mariana Chumbita; Cristina Pitart; Juan Ambrosioni; Verónica Rico; Daiana Agüero; Pedro Puerta-Alcalde; Nicole Garcia-Pouton; Francesc Marco; Carolina Garcia-Vidal; Alex Soriano; José Antonio Martínez Journal: Infect Dis Ther Date: 2021-06-11